HAV & B19 Testing Services
NHS Blood and Transplant · £6,100,000 · closes 22 Aug 2023
£6,100,000
Estimated value
Closed
Deadline
12 Jul 2023
Published
This tender has closed.
See what's open in architecture and engineering services, or get contracts like this in your inbox each morning — free.
About this contract
This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a fully integrated high throughput testing solution for the detection of hepatitis A virus (HAV) RNA and Parvovirus B19 DNA in partnership with NHSBT. Additionally, the solution must also be able to test for HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA as contingency during a business continuity need for NHSBTs . The solution must have the relevant UKCA marking to support this ability.<br/>Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver HAV & B19 Screening Services in partnership with NHSBT. All correspondence to: tennille.madigan@nhsbt.nhs.uk
Key dates
Source
Lot — bid on it if it fits
This contract has one lot. Bid if it suits your firm.
Who to contact
Similar open tenders
Contains public sector information licensed under OGL v3.0